Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics,…
Tag: Biopharmaceuticals
GSK Buys Aiolos Bio for Up to $1.4 Bln
Updated Jan. 9, 2024 2:35 am ET GSK said it bought biopharmaceutical company Aiolos Bio for…
WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
Merck to Buy Harpoon Therapeutics for $680 Million
Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680…
$19 Billion in a Week: AbbVie Makes Two Big Bets
Early last week, AbbVie was on every healthcare investment banker’s list. But with two quick deal…
Gene Editing Will Change Medicine—and Maybe Health Investing Too
It usually takes time for scientific discoveries in the lab to make their way to the…
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ET Roche Holding has agreed to buy the developer of…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs.